Health & Biotech
ASX Health Stocks: Global Health nabs Fujitsu contract, Althea generates $5.3m after property deal
EZZ Life Science is selling its products on Chemist Warehouse’s new online marketplace
ScoPo’s Powerplays: ASX health stocks fall, CSL recovers after sinking on latest Novo Nordisk news
PharmAust eyes US orphan drug designation after successful phase 1 motor neurone disease trial
Weed Week: Big win for cannabis as SAFER Banking Act approved; market remains robust in Australia
‘Nothing short of exceptional’: Melodiol’s psychedelics subsidiary shows promising Phase II PTSD trial results
ASX Health Stocks: Arovella to develop a world-first iNKT cell therapy targeting cancers
ASX Health Stocks: Kazia says goodbye to the ASX; IMEXHS wins $2m contract in Colombia
‘Remarkable outcome’: Paradigm achieves outstanding results in phase II osteoarthritis trial
ASX Health Stocks: Paradigm to seek TGA nod after successful trial; EMVision uses AI simulation
A global footprint: EZZ is expanding into Europe’s $38.2 billion dietary supplement market
ASX Health Stocks: Cleo Diagnostics delivers milestones, Radiopharm to begin Phase 1 study
Record sales drive third straight quarter of revenue growth for Melodiol subsidiary Mernova
PharmAust races for access to the US market after confirming its canine cancer treatment is safe for pooches
Neurotech treatment looks to be making a difference in children with PANDAS/PANS in Phase I/II clinical trial
ScoPo’s Powerplays: ASX health stocks fall but Dimerix up 150% on drug licensing deal
Dimerix soars on $230m licensing deal with ADVANZ PHARMA for DMX-200 into rare kidney disease
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
